Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Odyssey Group Intl Inc (OP: ODYY )

0.0237 -0.0006 (-2.47%)
Streaming Delayed Price Updated: 9:48 AM EST, Jan 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Odyssey Group Intl Inc

< Previous 1 2 3 Next >
BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Unveils New Corporate Website
Via Investor Brand Network
With People in Sports and Military Service Worried About Long-Term Consequences of Traumatic Brain Injuries, Odyssey Health, Inc. (ODYY) Is Working to Offer Relief with PRV-002 Concussion Drug
Via Investor Brand Network
Study Suggests Coronavirus Vaccine May Be Linked to Temporary Changes in Menstrual Cycles
Via Investor Brand Network
Exposures COVID-19
BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Dedicating Strategy Toward Acquisition, Creation of Lifesaving Medical Products
Via Investor Brand Network
Odyssey Group International Inc. (ODYY) Is ‘One to Watch’
Via Investor Brand Network
Loss of Y Chromosomes in Older Men Elevates Heart Disease Risk, Study Finds
Via Investor Brand Network
BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Featured in Stock2Me Podcast
Via Investor Brand Network
Topics Retirement
Exposures Pension
BioMedNewsBreaks – Odyssey Health Inc.’s (ODYY) Spokesperson Brett Favre to Be Featured on RedChip Money Report(R)
Via Investor Brand Network
Brett Favre Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
ORLANDO, FL / ACCESSWIRE / July 14, 2022 / RedChip Companies will air a new interview with Odyssey Health, Inc. (OTC Pink:ODYY), f/k/a Odyssey Group International, Inc., on The RedChip Money Report® on... 
From RedChip
Via AccessWire
BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Featured in Stock2Me Podcast Spotlighting Two-Time Olympic Gold Medalist Abby Wambach
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Study Finds That Sex, Ethnicity May Impact Risk of Suicide After Concussion
Via Investor Brand Network
BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Announces Successful Completion of Phase I Single Ascending Dosing for Intranasal Concussion Drug
Via Investor Brand Network
BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Poised to Successfully Commercialize Its Products
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Odyssey Health, Inc. (ODYY) Reports Positive Findings on Phase 1 Clinical Trials of PRV-002 for Concussions
Via Investor Brand Network
BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Completes Safety Evaluation of Cohort II for Novel Drug to Treat Concussion
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Odyssey Health, Inc. (ODYY) Taps Military Advisors to Address Target Market for PRV-002 Concussion Drug
Via Investor Brand Network
Odyssey Health, Inc. (ODYY) Targeting Achievement of Important Milestones, as It Progresses Clinical Trials of Novel Concussion Drug
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Sets Sights on US Phase II Clinical Trials with Focus on Military
Via Investor Brand Network
BioMedNewsBreaks – Odyssey Health Inc.’s (ODYY) Novel Drug Candidate Represents a Valuable Asset
Via Investor Brand Network
BioMedNewsBreaks – Odyssey Health Inc. (ODYY) CEO Spotlighted in RedChip Money Report Interview
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
BioMedNewsBreaks – Why Odyssey Health Inc. (ODYY) Is ‘One to Watch’
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Announces Positive Safety Findings from Clinical Trial of Concussion Drug
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Announces Positive Results from Phase I Clinical Trial for Novel Drug to Treat Concussion
Via Investor Brand Network
Exposures Product Safety
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.